Nicholas J. Short, MD | Authors

Highlighting PCR Monitoring of BCR-ABL1 to Identify Patients at High Risk of Relapse

December 02, 2016

As part of OncoTherapy Network’s coverage of the 58th Annual Meeting & Exposition of the American Society of Hematology (ASH), held December 3–6 in San Diego, California, we spoke with oncologist Nicholas J. Short, MD, of the Division of Cancer Medicine at University of Texas MD Anderson Cancer Center, in Houston.